Dow Up 1.31% Nasdaq Up 2.40%

MannKind Corp. (MNKD)

-NasdaqGM
5.53 Up 0.17(3.17%) 4:00PM EDT
|After Hours : 5.51 Down 0.02 (0.36%) 4:37PM EDT - Nasdaq Real Time Price
Prev Close:5.36
Open:5.41
Bid:5.48 x 100
Ask:5.53 x 500
1y Target Est:10.47
Beta:1.77
Earnings Date:Nov 3 - Nov 6 (Est.)
Day's Range:5.38 - 5.53
52wk Range:3.80 - 11.48
Volume:3,508,493
Avg Vol (3m):8,242,980
Market Cap:2.13B
P/E (ttm):N/A
EPS (ttm):-0.66
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
MNKDUp 3.17%2.13B
LLYUp 2.50%69.32B
GSKUp 0.05%104.80B
NVOUp 1.07%119.43B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.34
Quarterly EPS Est (Sep-14) :0.02
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):0.07

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback